Found 7 matching trials
Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes PHASE4 High blood glucose levels in hospitalized patients with diabetes are associ...
Show More Location
Grady Memorial Hospital
Learn More & Join Trial
Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita) PHASE3 The purpose of the study is to determine whether in patients with early typ...
Show More Location
University of Calgary
Learn More & Join Trial
ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia PHASE4 We have found that a 6-month course of insulin therapy after a short-term i...
Show More Location
Taipei Veterans General Hospital
Learn More & Join Trial
Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit PHASE4 The purpose of this study is to test whether a combination of two pills com...
Show More Location
Multiple Locations
Learn More & Join Trial
Randomized Sitagliptin Withdrawal Study (MK-0431-845) PHASE3 This is a trial of continuing sitagliptin versus withdrawing sitagliptin in...
Show More Location
Multiple Locations
Learn More & Join Trial
JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic Patients PHASE4 To evaluate the efficacy and safety of a new treatment regimen of metformin...
Show More Location
Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong
Learn More & Join Trial
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2) PHASE3 This is a safety and efficacy study of ertugliflozin (MK-8835/PF-04971729) ...
Show More Location
Multiple Locations
Learn More & Join Trial